Follow us on: Facebook Twitter Linkedin

John Stroh

Healthcare and Life Sciences

Josh Shinoff

Mr. Stroh has over 30 years of experience in senior management, operations, finance, investment banking and M&A, primarily in the medical technology & Life Science fields. John was President and CEO of Nanospectra Biosciences Inc, focused of tumor ablation using gold nanoparticles and a near infrared laser to ablate the tumor while leaving the healthy tissue surrounding the tumor intact. Prior to Nanospectra Mr. Stroh was Interim President and CEO of CryoFem Inc, a Cryoablation company focused in Womens Health. Prior to that Mr. Stroh was President, CEO and Director of NeoMatrix LLC, a breast cancer risk assessment medical device company based in Irvine, California. From 1984 until 2001, Mr. Stroh worked as a Managing Director and Vice President in the investment banking industry for Smith Barney, Shearson-Lehman Brothers, John Nuveen & Company and Piper Jaffray. During this period, he was instrumental in raising over $1 billion for client companies and consulted on over 100 M&A and strategic partnering transactions. He is on the Board of Directors for Orange Coast Memorial Hospital where he is also Chairman of the Foundation Committee, and the OCTANe Biomedical Leadership Council. Mr. Stroh earned a bachelor degree in business from California State University, Long Beach and also attended their Graduate School of Management. John is considered an expert in commercializing early stage growth companies and developing those companies through to a successful exit.

Back To Team